Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P P Sfikakis

Showing results (101-110 of 104) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 104 results.
Annals of the Rheumatic Diseases|February 5, 2008
EULAR recommendations for the management of Behçet diseaseG Hatemi, A Silman, D Bang, et al.
Arthritis Research & Therapy|April 16, 2020
Treatment modalities and drug survival in a systemic sclerosis real-life patient cohortS Panopoulos, Κ Chatzidionysiou, M G Tektonidou, et al.
Seminars in Arthritis and Rheumatism|December 31, 2020
Outcome of refractory to conventional and/or biologic treatment adult Still's disease following canakinumab treatment: Countrywide data in 50 patientsK Laskari, M G Tektonidou, C Katsiari, et al.
Rheumatology International|July 8, 2026
Disease-related and psychosocial factors associated with difficult-to-manage and treatment-refractory axial spondyloarthritis: insights from the Greek AxSpA RegistryN Kougkas, Konstantinos Tsafis, Dimitrios Deligeorgakis, et al.
Pageof 11

Showing results (101-110 of 104) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 104 results.
Annals of the Rheumatic Diseases|February 5, 2008
EULAR recommendations for the management of Behçet diseaseG Hatemi, A Silman, D Bang, et al.
Arthritis Research & Therapy|April 16, 2020
Treatment modalities and drug survival in a systemic sclerosis real-life patient cohortS Panopoulos, Κ Chatzidionysiou, M G Tektonidou, et al.
Seminars in Arthritis and Rheumatism|December 31, 2020
Outcome of refractory to conventional and/or biologic treatment adult Still's disease following canakinumab treatment: Countrywide data in 50 patientsK Laskari, M G Tektonidou, C Katsiari, et al.
Rheumatology International|July 8, 2026
Disease-related and psychosocial factors associated with difficult-to-manage and treatment-refractory axial spondyloarthritis: insights from the Greek AxSpA RegistryN Kougkas, Konstantinos Tsafis, Dimitrios Deligeorgakis, et al.
Pageof 11